Cloning Resources
  Recent News |  Tags |  Organ & Tissue Cloning |  Animal Cloning |  Definitions |  Archives |  About |  Newsletter |  Subscribe to CloningResources.com RSS Fee Subscribe

New enzyme research targets osteoporosis (9/25/2007)

Tags:
osteoporosis, bones

A University of Queensland biophysical chemist is working on new research which one day may slow down or switch off certain diseases.

Dr Gary Schenk from the School of Molecular and Microbial Sciences has been awarded an $85,000 UQ Research Excellence Award to study a group of enzymes including one linked to osteoporosis, a damaging bone disease.

"An enzyme works like a machine, you feed in a substrate (a particular molecule), the enzyme does something to it and out comes a product," Dr Schenk said.

"If you're able to inhibit this enzyme's action, you can in effect combat the disease associated with it."

Understanding how an enzyme works during a reaction is a key to its use as a drug target, with the mid-point of the process (known as the transition state) of particular interest.

"The problem with transition states is that they are very unstable and difficult to study," Dr Schenk said.

"One way we can investigate the 'shape' of this state is by using isotopes - atomic markers which are placed at particular positions in the substrate.

"This modified molecule may have chemical properties different from those of the original, an observation which can be used to 'visualise' the transition state," he said.

From this information synthetic molecules can be designed which mimic the real thing and may be able to stop the reaction taking place.

Dr Schenk will use the award to visit a laboratory at Utah State University, where he will collaborate with Professor Alvan Hengge, a world leader in the field.

Although in its early stages, Dr Schenk said that the project could lead to a range of breakthroughs including the creation of the next generation of antibiotics and agricultural products.

"The 1990s was the decade of genomics, cloning and sequencing. Now it's important to realise the potential enzymes have to advance research in my area and others.

"Not just understanding how enzymes work but utilising them as targets for the development of pharmaceuticals is likely to be a major research direction in Australia and the rest of the world."

Note: This story has been adapted from a news release issued by The University of Queensland

Personal Loan - Loans - New York Hotel - Best Credit Cards

Post Comments:

Search

Recent Articles
Immune response to human embryonic stem cells in mice suggests human therapy may face challenge 8/20/2008

Hydrogels provide scaffolding for growth of bone cells 8/19/2008

Neuroscientist awarded $3 million state stem cell grant 8/18/2008

Fifth young Stanford scientist gets stem cell funding from state institute 8/17/2008

Researchers Discover Tiny Cellular Antennae Trigger Neural Stem Cells 8/16/2008

Newly discovered molecular switch helps decide cell type in early embryo development 8/13/2008

Scientists identify single microRNA that controls blood vessel development 8/12/2008

Daley and colleagues create 20 disease-specific stem cell lines 8/9/2008

Putting microRNAs on the stem cell map 8/8/2008

Protein Key to Control Growth of Blood Cells 8/7/2008

Study finds molecule triggers hair growth in mouse embryos 8/6/2008

New $8.9 million project aims to unlock stem cell secrets 8/5/2008

Stanford fruit-fly study adds weight to theories about another type of adult stem cell 8/3/2008

First disease-specific stem cells from human skin cells 8/2/2008

Stem Cell Foundation plays critical funding role in major new ALS research announced today 8/1/2008

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2009 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer